UniversitiesUniversity of the WitwatersrandFatima Laher

Active, last published 2026

In hiv research and treatment

Fatima
Laher

Scholar

“Research focused on HIV Research and Treatment and adjacent fields.”

University of the Witwatersrand

South Africa

Claim Your Profile

H-index

3.3k

Citations

Fatima has not officially claimed their profile. If you are Fatima, claim it free.

Claim Your Profile

Honours

Claim this profile to start earning your Honours

Pioneer

LOCKED

Pathfinder

LOCKED

Scholar

EARNED

Innovator

LOCKED

Inventor

LOCKED

Catalyst

LOCKED

Expert

UPGRADE

01 · About the work

What I study

atima Laher is a researcher working on HIV Research and Treatment. A fuller summary will appear once they update their profile.

02 · Reach

Publication output and reach

Fatima's work has been cited 3,303 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.

03 · Research focus

Topics

HIV Research and Treatment×47HIV/AIDS Research and Interventions×34Adolescent Sexual and Reproductive Health×22HIV/AIDS drug development and treatment×14Vaccine Coverage and Hesitancy×11

04 · Where I am

Affiliations

Affiliation on published researchUniversity of the Witwatersrand, South AfricaDrawn from the institution listed on this researcher’s published work.

Research themes (UN SDGs)

05 · Selected work

Recent publications

9 works

1 May 2026Open access

Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, VRC07-523LS, and PGT121.414.LS infused intravenously or subcutaneously (HVTN 140/HPTN 101 part B): a phase 1, randomised trial Publisher site

The Lancet HIV, HIV Research and Treatment

12 Mar 2026Open access

AS01B-, MF59-, and alum-based adjuvants and HIV vaccine immunogenicity: a post-hoc cross-protocol comparison of results from HVTN 100, 107, 120, and 702 Publisher site

Frontiers in Immunology, HIV Research and Treatment

6 Oct 2025Open access1cites

Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV Publisher site

Nature Communications, SARS-CoV-2 and COVID-19 Research

30 Sept 2024Open access1cites

Male circumcision perceptions among HIV vaccine trial participants in Soweto: Qualitative study Publisher site

Journal of the Colleges of Medicine of South Africa, Genital Health and Disease

20 Sept 2024Open access

Safety and immunogenicity after a 30-month boost of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120/MF59 vaccine boost (HVTN 100): A phase 1–2 randomized double-blind placebo-controlled trial Publisher site

PLOS Global Public Health, HIV Research and Treatment

27 Aug 2024Open access2cites

Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses Publisher site

Viruses, HIV Research and Treatment

19 Jul 2024Open access

Early Online Publisher site

South African Medical Journal, High Altitude and Hypoxia

21 May 2024Open access1cites

Factors associated with reactogenicity to an investigational HIV vaccine regimen in HIV vaccine trials network 702 Publisher site

Vaccine, Vaccine Coverage and Hesitancy

Expert Academic Profiles go further

Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.

Explore Expert

Are you Fatima?

Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.

African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.

Claim Your Profile

Free to claim · takes a minute to verify it’s you

FatimaLaher

Honours

What I study

Publication output and reach

Topics

Affiliations

Recent publications

Are you Fatima?

Fatima
Laher